Product category:
Clinical chemistry analysis
News Release from: TTP LabTech | Subject: Acumen Explorer 405nm
Edited by the Laboratorytalk Editorial
Team on 04 May 2004
Roses are red, violets are blue
And this microplate cytometer now has a single violet laser excitation source for beta-Lactamase and blue fluorescent protein reporter systems
Following the success of the 488nm Acumen Explorer, TTP LabTech has launched a model with a single violet (405nm) laser excitation source The new Acumen Explorer 405nm model enables the beta-Lactamase and blue fluorescent protein reporter systems which, until now, have routinely been measured by bulk fluorescence readers as single point readouts
This article was originally published on Laboratorytalk on 2 Oct 2002 at 8.00am (UK)
Related stories
Fast, flexible and ultra-compact compound storage
Cherry pick from 100,000 stored samples in five seconds with this automated compound storage system for the pharmaceutical and biotech industries
Novel approach to accurate nanolitre pipetting
For many techniques used in drug discovery and proteomics/genomics, reducing assay cost by minimising reagent and sample usage is paramount
In contrast, Acumen Explorer offers multi-parametric analysis at high throughput allowing rapid, high content assays.
By fully exploiting the ratiometric detection of fluorescent enzyme substrates on a cell-by-cell basis, Acumen Explorer 405 provides greater assay sensitivity on plate formats ranging from 96 to the 1536 and 3456 microplates used in uHTS.
In addition, Acumen Explorer 405 offers enhanced compatibility with quantum dots as it increases the intensity of fluorescent emission by up to four-fold compared to its sister instrument.
Use of quantum dots expands the multiplexing capability of the Acumen Explorer, particularly in immunological detection methodologies.
"Acumen Explorer with a 405nm excitation source equips the drug discovery community with newly accessible technologies, providing an additional range of high content, high speed and highly sensitive cell-based assays" said Wayne Bowen, TTP LabTech's chief scientific officer.
"These innovations underpin our continued investment in fluorescence instrumentation to support existing and future customers".
Already adopted by major pharmaceutical and biotechnology companies, the Acumen Explorer laser-scanning fluorescence microplate cytometer enables the development and execution of powerful cell-based, high content screens.
The system offers what TTP says is unparalleled throughput flexibility in a wide range of cell-based assays.
• TTP LabTech: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
